Diabetes-associated cardiomyopathy and cell therapy

Cardiovascular Diseases: Nutritional and Therapeutic Interventions

Volumn , Issue , 2013, Pages 211-232

  Hochhauser, Edith ^a   Morozov, Michael ^a   Arad, Michael ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85051048551     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (124)

1. Abbott, R. D., R. P. Donahue, W. B. Kannel, and P. W. Wilson. 1988. The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study. JAMA 260(23): 3456-3460.
2. Abdel Aziz, M. T., M. F. El-Asmar, M. Haidara, H. M. Atta, N. K. Roshdy, L. A. Rashed et al. 2008. Effect of bone marrow-derived mesenchymal stem cells on cardiovascular complications in diabetic rats. Med Sci Monit 14(11): BR249-BR255.
3. Abdi, R., P. Fiorina, C. N. Adra, M. Atkinson, and M. H. Sayegh. 2008. Immunomodulation by mesenchymal stem cells: A potential therapeutic strategy for type 1 diabetes. Diabetes 57(7): 1759-1767.
4. Afzal, N., P. K. Ganguly, K. S. Dhalla, G. N. Pierce, P. K. Singal, and N. S. Dhalla. 1988. Beneficial effects of verapamil in diabetic cardiomyopathy. Diabetes 37(7): 936-942.
5. Afzal, N., G. N. Pierce, V. Elimban, R. E. Beamish, and N. S. Dhalla. 1989. Influence of verapamil on some subcellular defects in diabetic cardiomyopathy. Am J Physiol 256(4 Pt 1): E453-E458.
6. Amatruda, J. M., J. F. Richeson, S. L. Welle, R. G. Brodows, and D. H. Lockwood. 1988. The safety and efficacy of a controlled low-energy (‘very-low-calorie’) diet in the treatment of non-insulin-dependent diabetes and obesity. Arch Intern Med 148(4): 873-877.
7. An, D. and B. Rodrigues. 2006. Role of changes in cardiac metabolism in development of diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 291(4): H1489-H1506.
8. Anderson, J. W. and E. C. Konz. 2001. Obesity and disease management: Effects of weight loss on comorbid conditions. Obes Res 9(Suppl 4): 326S-334S.
9. Banke, N. H., A. R. Wende, T. C. Leone, J. M. O’Donnell, E. D. Abel, D. P. Kelly et al. 2010. Preferential oxidation of triacylglyceride-derived fatty acids in heart is augmented by the nuclear receptor PPARalpha. Circ Res 107(2): 233-241.
10. Barouch, L. A., D. E. Berkowitz, R. W. Harrison, C. P. O’Donnell, and J. M. Hare. 2003. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation 108(6): 754-759.
11. Bell, D. S. 1995. Diabetic cardiomyopathy. A unique entity or a complication of coronary artery disease? Diabetes Care 18(5): 708-714.
12. Berridge, M. J., M. D. Bootman, and H. L. Roderick. 2003. Calcium signalling: Dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4(7): 517-529.
13. Bertoni, A. G., A. Tsai, E. K. Kasper, and F. L. Brancati. 2003. Diabetes and idiopathic cardiomyopathy: a nationwide case-control study. Diabetes Care 26(10): 2791-2795.
14. Bjursell, M., A. Ahnmark, Y. M. Bohlooly, L. William-Olsson, M. Rhedin, X. R. Peng et al. 2007. Opposing effects of adiponectin receptors 1 and 2 on energy metabolism. Diabetes 56(3): 583-593.
15. Boudina, S. and E. D. Abel. 2006. Mitochondrial uncoupling: A key contributor to reduced cardiac efficiency in diabetes. Physiology (Bethesda) 21: 250-258.
16. Boudina, S. and E. D. Abel. 2007. Diabetic cardiomyopathy revisited. Circulation 115(25): 3213-3223.
17. Boudina, S., S. Sena, B. T. O’Neill, P. Tathireddy, M. E. Young, and E. D. Abel. 2005. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 112(17): 2686-2695.
18. Boyer, J. K., S. Thanigaraj, K. B. Schechtman, and J. E. Perez. 2004. Prevalence of ventricular diastolic dysfunction in asymptomatic, normotensive patients with diabetes mellitus. Am J Cardiol 93(7): 870-875.
19. Bugger, H. and E. D. Abel. 2009. Rodent models of diabetic cardiomyopathy. DMM Disease Models Mech 2(9-10): 454-466.
20. Cai, L., W. Li, G. Wang, L. Guo, Y. Jiang, and Y. James Kang. 2002. Hyperglycemia-induced apoptosis in mouse myocardium: Mitochondrial cytochrome c-mediated caspase-3 activation pathway. Diabetes 51(6): 1938-1948.
21. Camp, T. M., S. C. Tyagi, R. M. Senior, and M. R. Hayden. 2003. Gelatinase B(MMP-9) an apoptotic factor in diabetic transgenic mice. Diabetologia 46(10): 1438-1445.
22. Carley, A. N. and D. L. Severson. 2005. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta Mol Cell Biol Lipids 1734(2): 112-126.
23. Carugo, S., C. Giannattasio, I. Calchera, F. Paleari, M. G. Gorgoglione, A. Grappiolo et al. 2001. Progression of functional and structural cardiac alterations in young normotensive uncomplicated patients with type 1 diabetes mellitus. J Hypertens 19(9): 1675-1680.
24. Caux, F., E. Dubosclard, O. Lascols, B. Buendia, O. Chazouillères, A. Cohen et al. 2003. A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy. J Clin Endocrinol Metab 88(3): 1006-1013.
25. Chamberlain, G., J. Fox, B. Ashton, and J. Middleton. 2007. Concise review: Mesenchymal stem cells: Their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells 25(11): 2739-2749.
26. Chen, H. S., Y. X. Shan, T. L. Yang, H. D. Lin, J. W. Chen, S. J. Lin et al. 2005. Insulin deficiency downregulated heat shock protein 60 and IGF-1 receptor signaling in diabetic myocardium. Diabetes 54(1): 175-181.
27. Choi, K. M., Y. Zhong, B. D. Hoit, I. L. Grupp, H. Hahn, K. W. Dilly et al. 2002. Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol 283(4): H1398-H1408.
28. Christoffersen, C., E. Bollano, M. L. Lindegaard, E. D. Bartels, J. P. Goetze, C. B. Andersen, et al. 2003. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 144(8): 3483-3490.
29. Colditz, G. A., W. C. Willett, A. Rotnitzky, and J. E. Manson. 1995. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122(7): 481-486.
30. Conti, M., I. M. Renaud, B. Poirier, O. Michel, M. F. Belair, C. Mandet et al. 2004. High levels of myocardial antioxidant defense in aging nondiabetic normotensive Zucker obese rats. Am J Physiol Regul Integr Comp Physiol 286(4): R793-R800.
31. Coort, S. L., A. Bonen, G. J. van der Vusse, J. F. Glatz, and J. J. Luiken. 2007. Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: Role of sarcolemmal substrate transporters. Mol Cell Biochem 299(1-2): 5-18.
32. Devereux, R. B., M. J. Roman, M. Paranicas, M. J. O’Grady, E. T. Lee, T. K. Welty et al. 2000. Impact of diabetes on cardiac structure and function: The strong heart study. Circulation 101(19): 2271-2276.
33. Dhalla, N. S., X. Liu, V. Panagia, and N. Takeda. 1998. Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc Res 40(2): 239-247.
34. Doehner, W., M. Rauchhaus, P. Ponikowski, I. F. Godsland, S. von Haehling, D. O. Okonko et al. 2005. Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. J Am Coll Cardiol 46(6): 1019-1026.
35. Dong, F. and J. Ren. 2009. Adiponectin improves cardiomyocyte contractile function in db/db diabetic obese mice. Obesity (Silver Spring) 17(2): 262-268.
36. Duckworth, W. C., M. McCarren, and C. Abraira. 2001. Glucose control and cardiovascular complications: The VA diabetes trial. Diabetes Care 24(5): 942-945.
37. Eckel, J. and H. Reinauer. 1990. Insulin action on glucose transport in isolated cardiac myocytes: Signalling pathways and diabetes-induced alterations. Biochem Soc Trans 18(6): 1125-1127.
38. Elliott, P., B. Andersson, E. Arbustini, Z. Bilinska, F. Cecchi, P. Charron et al. 2008. Classification of the cardiomyopathies: A position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 29(2): 270-276.
39. Epstein, P. N., P. A. Overbeek, and A. R. Means. 1989. Calmodulin-induced early-onset diabetes in transgenic mice. Cell 58(6): 1067-1073.
40. Eurich, D., R. Tsuyuki, S. Majumdar, F. McAlister, R. Lewanczuk, M. Shibata et al. 2009. Metformin treatment in diabetes and heart failure: When academic equipoise meets clinical reality. Trials 10(1): 12.
41. Evaluation and Treatment of High Blood Cholesterol in Adults Expert Panel on Detection 2001. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285(19): 2486-2497.
42. Fang, C. X., F. Dong, D. P. Thomas, H. Ma, L. He, and J. Ren. 2008. Hypertrophic cardiomyopathy in high-fat diet-induced obesity: Role of suppression of forkhead transcription factor and atrophy gene transcription. Am J Physiol Heart Circ Physiol 295(3): H1206-H1215.
43. Fang, X., R. Palanivel, J. Cresser, K. Schram, R. Ganguly, F. S. Thong et al. 2010. An APPL1-AMPK signaling axis mediates beneficial metabolic effects of adiponectin in the heart. Am J Physiol Endocrinol Metab 299(5): E721-E729.
44. Friedman, J. M. and J. L. Halaas. 1998. Leptin and the regulation of body weight in mammals. Nature 395(6704): 763-770.
45. Fyhrquist, F. and O. Saijonmaa. 2008. Renin-angiotensin system revisited. J Intern Med 264(3): 224-236.
46. Galderisi, M. 2006. Diastolic dysfunction and diabetic cardiomyopathy: Evaluation by Doppler echocardiography. J Am Coll Cardiol 48(8): 1548-1551.
47. Galderisi, M., G. de Simone, P. Innelli, A. Turco, S. Turco, B. Capaldo et al. 2007. Impaired inotropic response in type 2 diabetes mellitus: A strain rate imaging study. Am J Hypertens 20(5): 548-555.
48. Garvey, W. T., D. Hardin, M. Juhaszova, and J. H. Dominguez. 1993. Effects of diabetes on myocardial glucose transport system in rats: Implications or diabetic cardiomyopathy. Am J Physiol 264(3 Pt 2): H837-H844.
49. Glenn, D. J., F. Wang, M. Nishimoto, M. C. Cruz, Y. Uchida, W. M. Holleran et al. 2011. A murine model of isolated cardiac steatosis leads to cardiomyopathy. Hypertension 57(2): 216-222.
50. Goldstein, B. J., R. G. Scalia, and X. L. Ma. 2009. Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med 6(1): 27-35.
51. Hadden, D. R., D. A. Montgomery, R. J. Skelly, E. R. Trimble, J. A. Weaver, E. A. Wilson et al. 1975. Maturity onset diabetes mellitus: Response to intensive dietary management. Br Med J 3(5978): 276-278.
52. Hamblin, M., D. B. Friedman, S. Hill, R. M. Caprioli, H. M. Smith, and M. F. Hill. 2007. Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy. J Mol Cell Cardiol 42(4): 884-895.
53. van Heerebeek, L., N. Hamdani, M. L. Handoko, I. Falcao-Pires, R. J. Musters, K. Kupreishvili et al. 2008. Diastolic stiffness of the failing diabetic heart: Importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 117(1): 43-51.
54. Holland, W. L., R. A. Miller, Z. V. Wang, K. Sun, B. M. Barth, H. H. Bui et al. 2011. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 17(1): 55-63.
55. Hoshida, S., N. Yamashita, K. Otsu, T. Kuzuya, and M. Hori. 2000. Cholesterol feeding exacerbates myocardial injury in Zucker diabetic fatty rats. Am J Physiol Heart Circ Physiol 278(1): H256-H262.
56. Iacobellis, G., M. C. Ribaudo, A. Zappaterreno, E. Vecci, C. Tiberti, U. Di Mario et al. 2003. Relationship of insulin sensitivity and left ventricular mass in uncomplicated obesity. Obes Res 11(4): 518-524.
57. Ilercil, A., R. B. Devereux, M. J. Roman, M. Paranicas, M. J. O’Grady, E. T. Lee et al. 2002. Associations of insulin levels with left ventricular structure and function in American Indians: The strong heart study. Diabetes 51(5): 1543-1547.
58. Iribarren, C., A. J. Karter, A. S. Go, A. Ferrara, J. Y. Liu, S. Sidney et al. 2001. Glycemic control and heart failure among adult patients with diabetes. Circulation 103(22): 2668-2673.
59. Issan, Y., E. Hochhauser, R. Kornowski, D. Leshem-Lev, E. Lev, R. Sharoni et al. 2012. Endothelial progenitor cell function inversely correlates with long-term glucose control in diabetic patients: Association with the attenuation of the heme oxygenase-adiponectin axis. Can J Cardiol 28(6): 728-736.
60. Iwabu, M., T. Yamauchi, M. Okada-Iwabu, K. Sato, T. Nakagawa, M. Funata et al. 2010. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 464(7293): 1313-1319.
61. Jarnert, C., L. Landstedt-Hallin, K. Malmberg, A. Melcher, J. Ohrvik, H. Persson et al. 2009. A randomized trial of the impact of strict glycaemic control on myocardial diastolic function and perfusion reserve: A report from the DADD (Diabetes mellitus And Diastolic Dysfunction) study. Eur J Heart Fail 11(1): 39-47.
62. Kim, J. K., Y. J. Kim, J. J. Fillmore, Y. Chen, I. Moore, J. Lee et al. 2001. Prevention of fat-induced insulin resistance by salicylate. J Clin Invest 108(3): 437-446.
63. Knowler, W. C., S. E. Fowler, R. F. Hamman, C. A. Christophi, H. J. Hoffman, A. T. Brenneman et al. 2009. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374(9702): 1677-1686.
64. Knowler, W. C., D. J. Pettitt, P. J. Savage, and P. H. Bennett. 1981. Diabetes incidence in Pima Indians: Contributions of obesity and parental diabetes. Am J Epidemiol 113(2): 144-156.
65. Konduracka, E., A. Gackowski, P. Rostoff, D. Galicka-Latala, W. Frasik, and W. Piwowarska. 2007. Diabetes-specific cardiomyopathy in type 1 diabetes mellitus: No evidence for its occurrence in the era of intensive insulin therapy. Eur Heart J 28(20): 2465-2471.
66. Lashin, O. and A. Romani. 2004. Hyperglycemia does not alter state 3 respiration in cardiac mitochondria from type-I diabetic rats. Mol Cell Biochem 267(1-2): 31-37.
67. Lee, Y., M. Y. Wang, T. Kakuma, Z. W. Wang, E. Babcock, K. McCorkle et al. 2001. Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J Biol Chem 276(8): 5629-5635.
68. Levy, D., R. J. Garrison, D. D. Savage, W. B. Kannel, and W. P. Castelli. 1990. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322(22): 1561-1566.
69. Liu, G. X., P. J. Hanley, J. Ray, and J. Daut. 2001. Long-chain acyl-coenzyme A esters and fatty acids directly link metabolism to K(ATP) channels in the heart. Circ Res 88(9): 918-924.
70. Luiken, J. J., D. M. Ouwens, D. D. Habets, G. C. van der Zon, W. A. Coumans, R. W. Schwenk et al. 2009. Permissive action of protein kinase C-zeta in insulin-induced CD36- and GLUT4 translocation in cardiac myocytes. J Endocrinol 201(2): 199-209.
71. Maisch, B., P. Alter, and S. Pankuweit. 2011. Diabetic cardiomyopathy-Fact or fiction? Herz 36(2): 102-115.
72. Maron, B. J., J. A. Towbin, G. Thiene, C. Antzelevitch, D. Corrado, D. Arnett et al. 2006. Contemporary definitions and classification of the cardiomyopathies: An American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113(14): 1807-1816.
73. McNulty, P. H. 2003. Insulin resistance and cardiac mass: The end of the beginning? Obes Res 11(4): 507-508.
74. Metzler, B., M. F. Schocke, P. Steinboeck, C. Wolf, W. Judmaier, M. Lechleitner et al. 2002. Decreased high-energy phosphate ratios in the myocardium of men with diabetes mellitus type I. J Cardiovasc Magn Reson 4(4): 493-502.
75. Meyer, C., M. Stumvoll, V. Nadkarni, J. Dostou, A. Mitrakou, and J. Gerich. 1998. Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest 102(3): 619-624.
76. Mokdad, A. H., E. S. Ford, B. A. Bowman, D. E. Nelson, M. M. Engelgau, F. Vinicor et al. 2001. The continuing increase of diabetes in the U.S. Diabetes Care 24(2): 412.
77. Mokuda, O., Y. Sakamoto, T. Ikeda, and H. Mashiba. 1990. Effects of anoxia and low free fatty acid on myocardial energy metabolism in streptozotocin-diabetic rats. Ann Nutr Metab 34(5): 259-265.
78. Morisco, C., G. Condorelli, V. Trimarco, A. Bellis, C. Marrone, J. Sadoshima et al. 2005. Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes. Circ Res 96(2): 180-188.
79. Murarka, S. and M. R. Movahed. 2010. Diabetic cardiomyopathy. J Card Fail 16(12): 971-979.
80. Naito, Z., E. Takashi, G. Xu, T. Ishiwata, K. Teduka, M. Yokoyama et al. 2003. Different influences of hyperglycemic duration on phosphorylated extracellular signal-regulated kinase 1/2 in rat heart. Exp Mol Pathol 74(1): 23-32.
81. Nauta, A. J. and W. E. Fibbe. 2007. Immunomodulatory properties of mesenchymal stromal cells. Blood 110(10): 3499-3506.
82. Nicolai, A., M. Li, D. H. Kim, S. J. Peterson, L. Vanella, V. Positano et al. 2009. Heme oxygenase-1 induction remodels adipose tissue and improves insulin sensitivity in obesity-induced diabetic rats. Hypertension 53(3): 508-515.
83. Nikolaidis, L. A. and T. B. Levine. 2004. Peroxisome proliferator activator receptors (PPAR), insulin resistance, and cardiomyopathy: Friends or foes for the diabetic patient with heart failure? Cardiol Rev 12(3): 158-170.
84. Nishio, Y., A. Kanazawa, Y. Nagai, H. Inagaki, and A. Kashiwagi. 2004. Regulation and role of the mitochondrial transcription factor in the diabetic rat heart. Ann N Y Acad Sci 1011: 78-85.
85. O’Keefe, J. H., Jr., J. M. Miles, W. H. Harris, R. M. Moe, and B. D. McCallister. 1999. Improving the adverse cardiovascular prognosis of type 2 diabetes. Mayo Clin Proc 74(2): 171-180.
86. O’Neill, B. T. and E. D. Abel. 2005. Akt1 in the cardiovascular system: Friend or foe? J Clin Invest 115(8): 2059-2064.
87. Ouwens, D. M., M. Diamant, M. Fodor, D. D. Habets, M. M. Pelsers, M. El Hasnaoui et al. 2007. Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification. Diabetologia 50(9): 1938-1948.
88. Pierce, G. N. and N. S. Dhalla. 1985. Heart mitochondrial function in chronic experimental diabetes in rats. Can J Cardiol 1(1): 48-54.
89. Poornima, I. G., P. Parikh, and R. P. Shannon. 2006. Diabetic cardiomyopathy: The search for a unifying hypothesis. Circ Res 98(5): 596-605.
90. Porada, C. D., E. D. Zanjani, and G. Almeida-Porad. 2006. Adult mesenchymal stem cells: A pluripotent population with multiple applications. Curr Stem Cell Res Ther 1(3): 365-369.
91. Regan, T. J., M. M. Lyons, S. S. Ahmed, G. E. Levinson, H. A. Oldewurtel, M. R. Ahmad et al. 1977. Evidence for cardiomyopathy in familial diabetes mellitus. J Clin Invest 60(4): 884-899.
92. Rodella, L. F., L. Vanella, S. J. Peterson, G. Drummond, R. Rezzani, J. R. Falck et al. 2008. Heme oxygenase-derived carbon monoxide restores vascular function in type 1 diabetes. Drug Metab Lett 2(4): 290-300.
93. Rosen, R., A. F. Rump, and P. Rosen. 1995. The ACE-inhibitor captopril improves myocardial perfusion in spontaneously diabetic (BB) rats. Diabetologia 38(5): 509-517.
94. Rubler, S., J. Dlugash, Y. Z. Yuceoglu, T. Kumral, A. W. Branwood, and A. Grishman. 1972. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 30(6): 595-602.
95. Saraiva, R. M., K. M. Minhas, M. Zheng, E. Pitz, A. Treuer, D. Gonzalez et al. 2007. Reduced neuronal nitric oxide synthase expression contributes to cardiac oxidative stress and nitroso-redox imbalance in ob/ob mice. Nitric Oxide 16(3): 331-338.
96. Sato, Y., F. Okajima, and S. Oikawa. 2010. Therapeutic points and meaning of dyslipidemia in diabetic patients. Nihon Rinsho 68(5): 905-910.
97. Savabi, F. 1988. Mitochondrial creatine phosphokinase deficiency in diabetic rat heart. Biochem Biophys Res Commun 154(1): 469-475.
98. Schannwell, C. M., M. Schneppenheim, S. Perings, G. Plehn, and B. E. Strauer. 2002. Left ventricular diastolic dysfunction as an early manifestation of diabetic cardiomyopathy. Cardiology 98(1-2): 33-39.
99. Schenk, S., M. Saberi, and J. M. Olefsky. 2008. Insulin sensitivity: Modulation by nutrients and inflammation. J Clin Invest 118(9): 2992-3002.
100. Schwartzbauer, G. and J. Robbins. 2001. The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. J Biol Chem 276(38): 35786-35793.
101. Severson, D. L. 2004. Diabetic cardiomyopathy: Recent evidence from mouse models of type 1 and type 2 diabetes. Can J Physiol Pharmacol 82(10): 813-823.
102. Sharma, N., E. B. Arias, M. P. Sajan, J. G. MacKrell, A. D. Bhat, R. V. Farese et al. 2010. Insulin resistance for glucose uptake and Akt2 phosphorylation in the soleus, but not epitrochlearis, muscles of old vs. adult rats. J Appl Physiol 108(6): 1631-1640.
103. Shindler, D. M., J. B. Kostis, S. Yusuf, M. A. Quinones, B. Pitt, D. Stewart et al. 1996. Diabetes mellitus, a predictor of morbidity and mortality in the Studies of Left Ventricular Dysfunction (SOLVD) trials and registry. Am J Cardiol 77(11): 1017-1020.
104. Shinmura, K., K. Tamaki, K. Saito, Y. Nakano, T. Tobe, and R. Bolli. 2007. Cardioprotective effects of short-term caloric restriction are mediated by adiponectin via activation of AMP-activated protein kinase. Circulation 116(24): 2809-2817.
105. Shulman, G. I. 2000. Cellular mechanisms of insulin resistance. J Clin Invest 106(2): 171-176.
106. da Silva Meirelles, L., P. C. Chagastelles, and N. B. Nardi. 2006. Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci 119(Pt 11): 2204-2213.
107. Smith, C. C., M. M. Mocanu, S. M. Davidson, A. M. Wynne, J. C. Simpkin, and D. M. Yellon. 2006. Leptin, the obesity-associated hormone, exhibits direct cardioprotective effects. Br J Pharmacol 149(1): 5-13.
108. Sun, Y., L. Chen, X. G. Hou, W. K. Hou, J. J. Dong, L. Sun et al. 2007. Differentiation of bone marrow-derived mesenchymal stem cells from diabetic patients into insulin-producing cells in vitro. Chin Med J (Engl) 120(9): 771-776.
109. Tao, L., E. Gao, X. Jiao, Y. Yuan, S. Li, T. A. Christopher et al. 2007. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115(11): 1408-1416.
110. Thornalley, P. J. and M. Vasak. 1985. Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydroxyl radicals. Biochim Biophys Acta 827(1): 36-44.
111. Turko, I. V. and F. Murad. 2003. Quantitative protein profiling in heart mitochondria from diabetic rats. J Biol Chem 278(37): 35844-35849.
112. Van Maldergem, L., J. Magre, T. E. Khallouf, T. Gedde-Dahl, Jr., M. Delepine, O. Trygstad et al. 2002. Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy. J Med Genet 39(10): 722-733.
113. Veksler, V. I., I. Murat, and R. Ventura-Clapier. 1991. Creatine kinase and mechanical and mitochondrial functions in hereditary and diabetic cardiomyopathies. Can J Physiol Pharmacol 69(6): 852-858.
114. Volarevic, V., A. Al-Qahtani, N. Arsenijevic, S. Pajovic, and M. L. Lukic. 2010. Interleukin-1 receptor antagonist (IL-1Ra) and IL-1Ra producing mesenchymal stem cells as modulators of diabetogenesis. Autoimmunity 43(4): 255-263.
115. Xie, Q. P., H. Huang, B. Xu, X. Dong, S. L. Gao, B. Zhang et al. 2009. Human bone marrow mesenchymal stem cells differentiate into insulin-producing cells upon microenvironmental manipulation in vitro. Differentiation 77(5): 483-491.
116. Xu, A., Y. Wang, K. S. Lam, and P. M. Vanhoutte. 2010. Vascular actions of adipokines molecular mechanisms and therapeutic implications. Adv Pharmacol 60: 229-255.
117. Yamauchi, T., Y. Nio, T. Maki, M. Kobayashi, T. Takazawa, M. Iwabu et al. 2007. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 13(3): 332-339.
118. Yang, X., Y. Shen, Z. Zhu, and A. Deng. 2006. Apoptosis signaling pathway in a subtotal nephrectomy rat model. J Huazhong Univ Sci Technolog Med Sci 26(4): 425-428.
119. Yu, C., Y. Chen, G. W. Cline, D. Zhang, H. Zong, Y. Wang et al. 2002. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 277(52): 50230-50236.
120. Yusuf, S., P. Sleight, J. Pogue, J. Bosch, R. Davies, and G. Dagenais. 2000. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342(3): 145-153.
121. Zhang, L., W. Keung, V. Samokhvalov, W. Wang, and G. D. Lopaschuk. 2010. Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle. Biochim Biophys Acta 1801(1): 1-22.
122. Zhang, N., J. Li, R. Luo, J. Jiang, and J. A. Wang. 2008. Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy. Exp Clin Endocrinol Diabetes 116(2): 104-111.
123. Zhang, Y., R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman. 1994. Positional cloning of the mouse obese gene and its human homologue. Nature 372(6505): 425-432.
124. Zhou, L., S. S. Deepa, J. C. Etzler, J. Ryu, X. Mao, Q. Fang et al. 2009. Adiponectin activates AMP-activated protein kinase in muscle cells via APPL1/LKB1-dependent and phospholipase C/Ca2+/Ca2+/calmodulin-dependent protein kinase kinase-dependent pathways. J Biol Chem 284(33): 22426-22435.